Effect of olmesartan medoxomil on the progression of coronary atherosclerosis in patients with stable angina pectoris

Trial Profile

Effect of olmesartan medoxomil on the progression of coronary atherosclerosis in patients with stable angina pectoris

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2014

At a glance

  • Drugs Olmesartan medoxomil (Primary)
  • Indications Angina pectoris; Atherosclerosis; Coronary artery disease
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Acronyms OLIVUS; OLIVUS-Ex
  • Most Recent Events

    • 01 Jul 2012 New source identified and integrated (University Hospital Medical Information Network - Japan UMIN000008309).
    • 01 Jul 2012 Actual initiation date (Jun 2012) as reported by University Hospital Medical Information Network - Japan.
    • 01 Jan 2012 Extension study results published in Atherosclerosis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top